Pramiracetam

  • IUPAC: N- [2 - ( diisopropylamino ) ethyl ]-2- oxopyrrolidin -1 -acetamide
  • Latin: Pramiracetamum
  • C14H27N3O2 ( Pramiracetam )
  • C14H27N3O2 · H2SO4 ( Pramiracetam sulfate )
  • 68497-62-1
  • 72869-16-0 ( Pramiracetam sulfate )
  • 75733-50-5 ( Pramiracetam hydrochloride)

N06BX16

Nootropics

  • 269.38 g · mol -1 ( Pramiracetam )
  • 367.46 g · mol -1 ( Pramiracetam sulfate )

4355 mg · kg -1 ( LD50, Mouse, oral, Pramiracetam sulfate )

Template: Infobox chemical / molecular formula search available

Pramiracetam is a drug from the group of nootropics. After traumatic brain injury Pramiracetam to improve the impaired mental abilities. Its mechanism of action is largely unknown. The therapeutic use of Pramiracetam regarded as controversial.

Production

The synthesis is carried out starting from 2- pyrrolidone in the first step by reaction with ethyl bromoacetate. In the second step, the target compound is obtained by reaction with N, N- diisopropylethylenediamine.

CAS registry number PubChem Anatomical Therapeutic Chemical Classification System Active ingredient 2-Pyrrolidone Digital Object Identifier Journal of Medicinal Chemistry
659427
de